映恩生物赴港上市,港股18A行业迎来第二春?

第一财经
14 Apr

映恩生物-B(09606.HK)将于4月15日在港交所正式挂牌上市。  市场颇为关注的是,该公司国际配售倍数超过14倍,募资金额超过2亿美元。同时,公司此次上市还吸引了包括BioNTech、富国基金、易方达等在内的15家国际长线资本及头部公募作为基石投资者。  而这一火爆认购情况对于“18A”板块(2018年4月,港交所推出新的《主板上市规则》,新增第18A章,允许未盈利、无收入的生物科技公司上市...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10